Bicara Therapeutics Inc. Common Stock (BCAX) — Financial Flexibility Index
Bicara Therapeutics Inc. Common Stock (BCAX) has a Financial Flexibility Index of -1.02x as of June 2026. Free cash flow of $-44.15 Million (operating CF $-44.21 Million minus capex $60.00K) represents -1% of total liabilities ($43.48 Million). Check BCAX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bicara Therapeutics Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Bicara Therapeutics Inc. Common Stock across 4 annual periods. For the full cash flow conversion analysis, see Bicara Therapeutics Inc. Common Stock cash flow conversion.
Annual Financial Flexibility Index for Bicara Therapeutics Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for Bicara Therapeutics Inc. Common Stock. Explore Bicara Therapeutics Inc. Common Stock (BCAX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.61x | $-106.55 Million | $-106.83 Million | $29.54 Million | ▼ -273.4% |
| 2024 | -0.97x | $-74.68 Million | $-74.75 Million | $77.32 Million | ▲ +66.8% |
| 2023 | -2.91x | $-45.04 Million | $-45.63 Million | $15.47 Million | ▼ -118.9% |
| 2022 | -1.33x | $-31.88 Million | $-32.08 Million | $23.98 Million | — |